Description
The global enteric disease testing market was valued at USD 3.832 billion in 2020 and is expected to reach USD 5.0123 billion with a CAGR of 3.8% during the forecast period, 2021-2027. The increasing use of enteric disease testing, rising molecular diagnostic technology, and advancements in disease testing technologies are the major factors restoring the growth of the global enteric disease testing market. Furthermore, an increase in involvement from the governments to advance the living standard in individuals is among the key factors likely over the forecast period to drive the global market’s growth for enteric disease testing.
